Induction	O
of	O
Id	O
-	O
1	O
by	O
FGF	O
-	O
2	O
involves	O
activity	O
of	O
EGR	O
-	O
1	O
and	O
sensitizes	O
neuroblastoma	B-Cell
cells	I-Cell
to	O
cell	B-Cell
death	O
.	O

Inhibitor	O
of	O
differentiation	O
-	O
1	O
(	O
Id	O
-	O
1	O
)	O
is	O
a	O
member	O
of	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
family	O
of	O
proteins	O
that	O
regulate	O
gene	O
transcription	O
through	O
their	O
inhibitory	O
binding	O
to	O
basic	O
-	O
HLH	O
transcription	O
factors	O
.	O

Similarly	O
to	O
other	O
members	O
of	O
this	O
family	O
,	O
Id	O
-	O
1	O
is	O
involved	O
in	O
the	O
repression	O
of	O
cell	B-Cell
differentiation	O
and	O
activation	O
of	O
cell	B-Cell
growth	O
.	O

The	O
dual	O
function	O
of	O
Id	O
-	O
1	O
,	O
inhibition	O
of	O
differentiation	O
,	O
and	O
stimulation	O
of	O
cell	B-Cell
proliferation	O
,	O
might	O
be	O
interdependent	O
,	O
as	O
cell	B-Cell
differentiation	O
is	O
generally	O
coupled	O
with	O
the	O
exit	O
from	O
the	O
cell	B-Cell
cycle	O
.	O

Fibroblast	O
growth	O
factor	O
-	O
2	O
(	O
FGF	O
-	O
2	O
)	O
has	O
been	O
reported	O
to	O
play	O
multiple	O
roles	O
in	O
different	O
biological	O
processes	O
during	O
development	O
of	O
the	O
central	B-Anatomical_system
nervous	I-Anatomical_system
system	I-Anatomical_system
(	O
CNS	B-Anatomical_system
)	O
.	O

In	O
addition	O
,	O
FGF	O
-	O
2	O
has	O
been	O
described	O
to	O
induce	O
"	O
neuronal	B-Cell
-	O
like	O
"	O
differentiation	O
and	O
trigger	O
apoptosis	O
in	O
neuroblastoma	B-Cell
SK	I-Cell
-	I-Cell
N	I-Cell
-	I-Cell
MC	I-Cell
cells	I-Cell
.	O

Although	O
regulation	O
of	O
Id	O
-	O
1	O
protein	O
by	O
several	O
mitogenic	O
factors	O
is	O
well	O
-	O
established	O
,	O
little	O
is	O
known	O
about	O
the	O
role	O
of	O
FGF	O
-	O
2	O
in	O
the	O
regulation	O
of	O
Id	O
-	O
1	O
.	O

Using	O
human	O
neuroblastoma	B-Cell
cell	I-Cell
line	I-Cell
,	O
SK	B-Cell
-	I-Cell
N	I-Cell
-	I-Cell
MC	I-Cell
,	O
we	O
found	O
that	O
treatment	O
of	O
these	O
cells	B-Cell
with	O
FGF	O
-	O
2	O
resulted	O
in	O
early	O
induction	O
of	O
both	O
Id	O
-	O
1	O
mRNA	O
and	O
protein	O
.	O

The	O
induction	O
occurs	O
within	O
1	O
h	O
from	O
FGF	O
-	O
2	O
treatment	O
and	O
is	O
mediated	O
by	O
ERK1	O
/	O
2	O
pathway	O
,	O
which	O
in	O
turn	O
stimulates	O
expression	O
of	O
the	O
early	O
growth	O
response	O
-	O
1	O
(	O
Egr	O
-	O
1	O
)	O
transcription	O
factor	O
.	O

We	O
also	O
demonstrate	O
direct	O
interaction	O
of	O
Egr	O
-	O
1	O
with	O
Id	O
-	O
1	O
promoter	O
in	O
vitro	O
and	O
in	O
cell	B-Cell
culture	I-Cell
.	O

Finally	O
,	O
inhibition	O
of	O
Id	O
-	O
1	O
expression	O
results	O
in	O
G	O
(	O
2	O
)	O
/	O
M	O
accumulation	O
of	O
FGF	O
-	O
2	O
-	O
treated	O
cells	B-Cell
and	O
delayed	O
cell	B-Cell
death	O
.	O

